195 related articles for article (PubMed ID: 30039418)
1. Application of Virtual Screening Approaches for the Identification of Small Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.
Luise C; Robaa D
Methods Mol Biol; 2018; 1824():347-370. PubMed ID: 30039418
[TBL] [Abstract][Full Text] [Related]
2. Identification and Structure-Activity Relationship Studies of Small-Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.
Robaa D; Wagner T; Luise C; Carlino L; McMillan J; Flaig R; Schüle R; Jung M; Sippl W
ChemMedChem; 2016 Oct; 11(20):2327-2338. PubMed ID: 27634332
[TBL] [Abstract][Full Text] [Related]
3. Exploring aromatic cage flexibility of the histone methyllysine reader protein Spindlin1 and its impact on binding mode prediction: an in silico study.
Luise C; Robaa D; Sippl W
J Comput Aided Mol Des; 2021 Jun; 35(6):695-706. PubMed ID: 34081238
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 Inhibitors.
Luise C; Robaa D; Regenass P; Maurer D; Ostrovskyi D; Seifert L; Bacher J; Burgahn T; Wagner T; Seitz J; Greschik H; Park KS; Xiong Y; Jin J; Schüle R; Breit B; Jung M; Sippl W
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072837
[TBL] [Abstract][Full Text] [Related]
5. Computer-Aided Drug Design Methods.
Yu W; MacKerell AD
Methods Mol Biol; 2017; 1520():85-106. PubMed ID: 27873247
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for histone H3 "K4me3-K9me3/2" methylation pattern readout by Spindlin1.
Zhao F; Liu Y; Su X; Lee JE; Song Y; Wang D; Ge K; Gao J; Zhang MQ; Li H
J Biol Chem; 2020 Dec; 295(49):16877-16887. PubMed ID: 32994220
[TBL] [Abstract][Full Text] [Related]
7. Use of machine learning approaches for novel drug discovery.
Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical virtual screening approaches in small molecule drug discovery.
Kumar A; Zhang KY
Methods; 2015 Jan; 71():26-37. PubMed ID: 25072167
[TBL] [Abstract][Full Text] [Related]
9. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Cross JB
Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
[TBL] [Abstract][Full Text] [Related]
10. The Use of Dynamic Pharmacophore in Computer-Aided Hit Discovery: A Case Study.
Perricone U; Wieder M; Seidel T; Langer T; Padova A
Methods Mol Biol; 2018; 1824():317-333. PubMed ID: 30039416
[TBL] [Abstract][Full Text] [Related]
11. Developing Spindlin1 small-molecule inhibitors by using protein microarrays.
Bae N; Viviano M; Su X; Lv J; Cheng D; Sagum C; Castellano S; Bai X; Johnson C; Khalil MI; Shen J; Chen K; Li H; Sbardella G; Bedford MT
Nat Chem Biol; 2017 Jul; 13(7):750-756. PubMed ID: 28504676
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H
Reiner D; Seifert L; Deck C; Schüle R; Jung M; Stark H
Sci Rep; 2020 Aug; 10(1):13558. PubMed ID: 32782417
[TBL] [Abstract][Full Text] [Related]
13. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1).
Xiong Y; Greschik H; Johansson C; Seifert L; Bacher J; Park KS; Babault N; Martini M; Fagan V; Li F; Chau I; Christott T; Dilworth D; Barsyte-Lovejoy D; Vedadi M; Arrowsmith CH; Brennan P; Fedorov O; Jung M; Farnie G; Liu J; Oppermann U; Schüle R; Jin J
J Med Chem; 2019 Oct; 62(20):8996-9007. PubMed ID: 31260300
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
16. BEAR, a novel virtual screening methodology for drug discovery.
Degliesposti G; Portioli C; Parenti MD; Rastelli G
J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
[TBL] [Abstract][Full Text] [Related]
17. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
18. An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches.
Li L; Liu S; Wang B; Liu F; Xu S; Li P; Chen Y
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762253
[TBL] [Abstract][Full Text] [Related]
19. Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
Guedes RA; Serra P; Salvador JA; Guedes RC
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438821
[TBL] [Abstract][Full Text] [Related]
20. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
